"California Supreme Court Rules In Favor Of Gilead Sciences In 'Duty To Innovate' Case Involving HIV Drugs" - Reuters
California's highest court on Monday ruled in favor of Gilead Sciences GILD.O, in a case addressing whether manufacturers of drugs that are considered safe must try developing drugs that could be safer.
A court decided that Gilead Sciences doesn't have to keep trying to make safer HIV medicines than the ones it already sells. This is good news for the company because it means courts won't force drug makers to keep inventing better versions of medicines that already work.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.